Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Samantha Hocking
New Diagnostic Criteria for Obesity
Prof Rukshen Weerasooriya
Fatal Arrhythmias – The Patterns GPs Don’t Want to Miss
Dr Rupert Hinds
Infant Allergy Cases
Prof Andrew Sindone
How to Use the BNP Test in General Practice
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
